Yayınlar & Eserler

Makaleler 24
Tümü (24)
SCI-E, SSCI, AHCI (20)
SCI-E, SSCI, AHCI, ESCI (22)
ESCI (2)
Scopus (21)
TRDizin (2)
Diğer Yayınlar (2)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 27

1. Role of the AKT1 and CTNNB1 mutations in paclitaxel resistance

The 49th FEBS Congress, İstanbul, Türkiye, 5 - 09 Temmuz 2025, ss.286, (Özet Bildiri)

6. Investigation of MTHFR C677T gene polymorphism in patient with lung cancer.

Third International congress of Molecular Medicine, İstanbul, Türkiye, ss.342, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

7. Identification of AKT1/CTNNB1 mutations conferring cetuximab and chemotherapeutic drugs resistance in colorectal cancer treatment

2nd Eurosia Biochemical Approaches and Technologies Congress, Antalya, Türkiye, 26 - 29 Ekim 2019, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

8. The cytotoxic effects of Ornithogalum oligophyllum and Ornithogalum umbellatum extracts

2nd Eurasian Biochemical Approaches & Technologies (EBAT) Congress, Antalya, Türkiye, 26 - 29 Ekim 2019, ss.157, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

10. Antioxidant activities of Ornithogalum umbellatum

II. Eurasian Agriculture and Natural Sciences Congress, Baku, Azerbaycan, 11 - 15 Eylül 2018, ss.130, (Tam Metin Bildiri)

11. Antioxidant and in vitro enzyme inhibitory effects of Ornithogalum oligophyllum

2nd International Congress on Advances in Bioscience and Biotechnology (ICABB), Podgorica, Karadağ, 26 - 30 Haziran 2018, ss.41, (Tam Metin Bildiri)

12. Identification of the association between BHMT, CHDH and PEMT polymorphisms and rectal cancer in a Turkish population

2nd International Congress on Advances in Bioscience and Biotechnology (ICABB), Podgorica, Karadağ, 26 - 30 Haziran 2018, ss.45, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

13. In vitro antioxidant, DNA protection capacities and cytotoxic activities of Allium kurtzianum extracts

The 21th International Congress Phytopharm 2017 and 10th Anniversary of the TCM Research Center Graz, Graz, Avusturya, 2 - 05 Temmuz 2017, cilt.15, ss.71, (Tam Metin Bildiri)

14. Helleborus vesicarius Aucher Bitkisinin Antioksidan ve Antikanser Aktiviteleri

22. Bİtkisel İlaç Hammaddeleri Toplantısı, Trabzon, Türkiye, 31 Ağustos - 05 Eylül 2016, ss.142, (Tam Metin Bildiri)

16. Association of Polymorphisms in One Carbon Metabolism Genes with Lung Cancer in a Turkish Population

International Symposium on Advances in Predictive & Personalized Medicine, İstanbul, Türkiye, 2 - 03 Nisan 2015, ss.14, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

17. Investigation of association between paraoxonase-1 192/55 polymorphisms and serum paraoxonase activity in lung cancer

9th International Meeting of the International-Society-for-the-Study-of-Xenobiotics(ISSX), İstanbul, Türkiye, 4 - 08 Eylül 2010, cilt.42, ss.263, (Özet Bildiri) Sürdürülebilir Kalkınma identifier

18. Degredation mechanisms responsible for decreased levels of a neutral endopeptidase (NEP) variant allozyme.

49th American Society of Cell Biology Meeting,, San Diego, Amerika Birleşik Devletleri, 4 - 09 Aralık 2009, ss.1, (Tam Metin Bildiri)

19. Assocıatıon Of Apurınıc/Apyrımıdınıc Endonuclease (Ape1) Gene Polymorphısms Wıth Lung Cancer In Males.

III. International Congress of Molecular Medicine, İstanbul, Türkiye, 5 - 08 Mayıs 2009, cilt.61, sa.3, ss.330, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

20. Cytosolic, 5’-nucleotidase III (NT5C3) gene sequence variations and functional genomics

American Society of Clinical Pharmacology and Therapeutics Annual Meeting,, Washington, Amerika Birleşik Devletleri, 19 - 22 Mart 2009, ss.47, (Tam Metin Bildiri)

21. CYTOSOLIC 5 '-NUCLEOTIDASE III (NT5C3) GENE SEQUENCE VARIATION AND FUNCTIONAL GENOMICS: CYTOSINE ARABINOSIDE AND GEMCITABINE PHARMACOGENETICS

110th Annual Meeting of the American-Society-for-Clinical-Pharmacology-and-Therapeutics, Maryland, Amerika Birleşik Devletleri, 18 - 21 Mart 2009, cilt.85 identifier

22. Gemcitabine pharmacogenomics: deoxycytidine kinase and cytidylate kinase gene resequencing and functional genomics.

American Society of Clinical Pharmacology and Therapeutics Annual Meeting, Orlando, Amerika Birleşik Devletleri, 2 - 05 Nisan 2008, ss.18, (Tam Metin Bildiri)

23. Gemcitabine pharmacogenomics: Deoxycytidine kinase (DCK) and cytidine monophosphate kinase (CMPK) gene sequence variation and functional genomics.

109th Annual Meeting of the American-Society-for-Clinical-Pharmacology-and-Therapeutics, Florida, Amerika Birleşik Devletleri, 2 - 05 Nisan 2008, cilt.83, (Özet Bildiri) identifier

24. NAD(P)H: Quinone Oxidoreductase Polymorphism and its Association to Lung Cancer in a Turkish Population

14 th IFCC-FE SCC European Congress of Clinical Chemistry and Laboratory Medicine, Prague, Çek Cumhuriyeti, 26 - 31 Mayıs 2001, ss.317, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

25. Lung Cancer Risk in Relation to Dopamine 2 Receptor Gene (DRD2)

14 th IFCC-FE SCC European Congress of Clinical Chemistry and Laboratory Medicine,, Prague, Çek Cumhuriyeti, 26 - 31 Mayıs 2001, ss.317, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

26. Identification of NAD(P)H: Quinone Oxidoreductase 609 C®T Polymorphism in a Turkish Population.

XVIth National Congress of Biochemistry. The Second International Bioscience Days, İzmir, Türkiye, 23 - 27 Ekim 2000, ss.17, (Tam Metin Bildiri)

27. Dopamine D2 Receptor Gene (DRD2) Polymorphisms in a Turkish Population

4th Xenobiotic Metabolism and Toxicity Workshop of Balkan Countries, Antalya, Türkiye, 12 - 16 Nisan 2000, ss.51, (Tam Metin Bildiri)
Metrikler

Yayın

57

Yayın (WoS)

25

Yayın (Scopus)

21

Atıf (WoS)

840

H-İndeks (WoS)

12

Atıf (Scopus)

864

H-İndeks (Scopus)

12

Atıf (Scholar)

86

H-İndeks (Scholar)

2

Proje

39

Tez Danışmanlığı

7

Açık Erişim

24
BM Sürdürülebilir Kalkınma Amaçları